Global Non-Drug Eluting Device Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application (Cardiovascular Diseases, Peripheral Artery Disease, Oncology, Urology and Other Applications), Material Type, End-User, Region, By Countr

Global Non-Drug Eluting Device Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application (Cardiovascular Diseases, Peripheral Artery Disease, Oncology, Urology and Other Applications), Material Type, End-User, Region, By Country: 2020-2030

Background

A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Non-Drug Eluting Device Market (2024 Edition)”. According to the report, Global Non-Drug Eluting Device Market was valued at USD 6526.26 Million and is expected to grow at a CAGR of 5.3% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by Application (Cardiovascular Diseases, Peripheral Artery Disease, Oncology, Urology and Other Applications), By Material Type (Cobalt-Chromium, Stainless Steel, Nitinol and Other Material Types) and By End-User (Hospitals & Clinics and Ambulatory Surgical Centers)

Market Overview

The Non-Drug Eluting Device Market is witnessing steady growth, primarily driven by the increasing demand for medical devices that do not rely on drug delivery mechanisms but are crucial in managing various medical conditions. Non-drug eluting devices, such as bare-metal stents, catheters, and implantable medical devices, are widely used in procedures where drug elution is not necessary, or where a more mechanical or structural intervention is required. These devices play a key role in the treatment of cardiovascular diseases, orthopedic conditions, and general surgeries.

In the cardiovascular sector, bare-metal stents remain in use for certain patient populations, despite the widespread adoption of drug eluting stents. These stents offer structural support to arteries without releasing drugs, making them suitable for patients who may not benefit from drug elution or those at risk of complications. The demand for non-drug eluting devices is also growing in the orthopedic sector, where devices such as spinal implants and joint replacements are critical for treating musculoskeletal disorders and injuries.

Moreover, advancements in material science and engineering have led to the development of more durable, biocompatible, and patient-friendly non-drug eluting devices. The increasing focus on minimally invasive surgical procedures, which often rely on non-drug eluting devices like catheters and guidewires, has further driven market growth. As healthcare systems worldwide aim to improve patient outcomes and reduce recovery times, the adoption of these devices is expected to continue rising.

Segment Insights

The cardiovascular segment dominates the Non-Drug Eluting Device Market, representing around 50% of the market in 2023. Bare-metal stents and other cardiovascular devices remain essential for certain patient groups.

Geographical Insights

The Americas dominate the Non-Drug Eluting Device Market, largely due to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and ongoing innovations in medical device technologies. The Asia-Pacific region is also experiencing significant growth, driven by rising healthcare expenditure and increasing demand for minimally invasive procedures.

Market Segmentation

By Application:

• Cardiovascular Diseases
• Peripheral Artery Disease
• Oncology
• Urology
• Other Applications

By Material Type:

• Cobalt-Chromium
• Stainless Steel
• Nitinol
• Other Material Types

By End-User:

• Hospitals & Clinics
• Ambulatory Surgical Centers

By Geography

• Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
• Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
• Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Non-Drug Eluting Device Market include:

• Smith & Nephew plc.
• Integra Lifesciences
• ConMed Corporation
• Peter Surgical
• Boston Scientific Corporation
• DemeTECH Corporation
• Teleflex Incorporated
• Medtronic
• Stryker Corporation
• B. Braun Melsungen AG
• Johnson & Johnson Services Inc.
• Other Leading Companies

Reasons to buy this report:

• In-Depth Comparative Assessment of Top 20 Markets in the Non-Drug Eluting Device Market Material Type: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
• Comprehensive Historical, Present, and Future Analytics of the Non-Drug Eluting Device Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Non-Drug Eluting Device Market.
• Detailed Analysis of Non-Drug Eluting Device Market By Application, Material Type, and End-User Across 20 Countries
• Beyond the Purchase: 90 Days of Support
• Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
• Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
• Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
• Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
• Strategic Material Type Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.

*Please Note: The report will be delivered in 2 business days upon order confirmation*